FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for the treatment of toxic liver damage. Use L-lysine tiazotate.
EFFECT: method allows to increase the effectiveness of therapy while reducing toxicity.
1 cl, 2 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
HEPATOPROTECTIVE, CARDIOPROTECTIVE AND PLACENTAPROTECTIVE, UTEROLITH AND NO-MIMETIC COMBINED DRUG | 2015 |
|
RU2597785C1 |
METHOD OF TREATING EXPERIMENTAL CHEMICAL BURNS AND CATARACTS MODELED ON CHINCHILLAS RABBITS | 2019 |
|
RU2711543C1 |
USING ACIZOL AS HEPATOPROTECTING AGENT | 2004 |
|
RU2260427C1 |
HEPATOPROTECTIVE AGENT FROM ALGAE | 2013 |
|
RU2528898C1 |
METHOD OF TOXIC LIVER DAMAGE REDUCTION | 2007 |
|
RU2342132C2 |
AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
METHOD FOR TREATMENT OF ALCOHOLIC CARDIOMYOPATHY | 2017 |
|
RU2642298C1 |
HEPATOPROTECTOR | 2011 |
|
RU2454243C1 |
HERBAL AGENT POSSESSING HEPATOPROTECTIVE ACTION | 2014 |
|
RU2554493C1 |
METHOD FOR STIMULATING THE PROCESSES OF NATURAL HEPATIC REGENERATION | 2003 |
|
RU2252026C1 |
Authors
Dates
2019-02-11—Published
2018-02-13—Filed